Literature DB >> 17537965

Regulation of the intermediate filament protein nestin at rodent neuromuscular junctions by innervation and activity.

Hyuno Kang1, Le Tian, Young-Jin Son, Yi Zuo, Diane Procaccino, Flora Love, Christopher Hayworth, Joshua Trachtenberg, Michelle Mikesh, Lee Sutton, Olga Ponomareva, John Mignone, Grigori Enikolopov, Mendell Rimer, Wesley Thompson.   

Abstract

The intermediate filament nestin is localized postsynaptically at rodent neuromuscular junctions. The protein forms a filamentous network beneath and between the synaptic gutters, surrounds myofiber nuclei, and is associated with Z-discs adjacent to the junction. In situ hybridization shows that nestin mRNA is synthesized selectively by synaptic myonuclei. Although weak immunoreactivity is present in myelinating Schwann cells that wrap the preterminal axon, nestin is not detected in the terminal Schwann cells (tSCs) that cover the nerve terminal branches. However, after denervation of muscle, nestin is upregulated in tSCs and in SCs within the nerve distal to the lesion site. In contrast, immunoreactivity is strongly downregulated in the muscle fiber. Transgenic mice in which the nestin neural enhancer drives expression of a green fluorescent protein (GFP) reporter show that the regulation in SCs is transcriptional. However, the postsynaptic expression occurs through enhancer elements distinct from those responsible for regulation in SCs. Application of botulinum toxin shows that the upregulation in tSCs and the loss of immunoreactivity in muscle fibers occurs with blockade of transmitter release. Extrinsic stimulation of denervated muscle maintains the postsynaptic expression of nestin but does not affect the upregulation in SCs. Thus, a nestin-containing cytoskeleton is promoted in the postsynaptic muscle fiber by nerve-evoked muscle activity but suppressed in tSCs by transmitter release. Nestin antibodies and GFP driven by nestin promoter elements serve as excellent markers for the reactive state of SCs. Vital imaging of GFP shows that SCs grow a dynamic set of processes after denervation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537965      PMCID: PMC6672248          DOI: 10.1523/JNEUROSCI.0621-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo.

Authors:  M Akaaboune; S M Culican; S G Turney; J W Lichtman
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Glial cells promote muscle reinnervation by responding to activity-dependent postsynaptic signals.

Authors:  F M Love; W J Thompson
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

3.  From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction.

Authors:  M J Marques; J A Conchello; J W Lichtman
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 4.  Induction, assembly, maturation and maintenance of a postsynaptic apparatus.

Authors:  J R Sanes; J W Lichtman
Journal:  Nat Rev Neurosci       Date:  2001-11       Impact factor: 34.870

5.  Synapse-glia interactions at the mammalian neuromuscular junction.

Authors:  D Rochon; I Rousse; R Robitaille
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

6.  Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knock-out mice.

Authors:  L Carlsson; Z Li; D Paulin; L E Thornell
Journal:  Exp Cell Res       Date:  1999-08-25       Impact factor: 3.905

7.  Specific and innervation-regulated expression of the intermediate filament protein nestin at neuromuscular and myotendinous junctions in skeletal muscle.

Authors:  S Vaittinen; R Lukka; C Sahlgren; J Rantanen; T Hurme; U Lendahl; J E Eriksson; H Kalimo
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression.

Authors:  Alban de Kerchove D'Exaerde; Jean Cartaud; Aymeric Ravel-Chapuis; Thierry Seroz; Fabien Pasteau; Lindsay M Angus; Bernard J Jasmin; Jean-Pierre Changeux; Laurent Schaeffer
Journal:  EMBO Rep       Date:  2002-10-22       Impact factor: 8.807

9.  Studies of excitable membranes. II. A comparison of specializations at neuromuscular junctions and nonjunctional sarcolemmas of mammalian fast and slow twitch muscle fibers.

Authors:  M H Ellisman; J E Rash; L A Staehelin; K R Porter
Journal:  J Cell Biol       Date:  1976-03       Impact factor: 10.539

10.  Muscle activity and muscle agrin regulate the organization of cytoskeletal proteins and attached acetylcholine receptor (AchR) aggregates in skeletal muscle fibers.

Authors:  G Bezakova; T Lømo
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

View more
  27 in total

Review 1.  Neuron-glia interactions: the roles of Schwann cells in neuromuscular synapse formation and function.

Authors:  Yoshie Sugiura; Weichun Lin
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.

Authors:  Elizabeth L Whitlock; Terence M Myckatyn; Alice Y Tong; Andrew Yee; Ying Yan; Christina K Magill; Philip J Johnson; Susan E Mackinnon
Journal:  Exp Neurol       Date:  2010-07-12       Impact factor: 5.330

Review 3.  Perisynaptic Schwann Cells at the Neuromuscular Synapse: Adaptable, Multitasking Glial Cells.

Authors:  Chien-Ping Ko; Richard Robitaille
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

4.  Motor axon regeneration and muscle reinnervation in young adult and aged animals.

Authors:  Hyuno Kang; Jeff W Lichtman
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

5.  Terminal Schwann cells participate in the competition underlying neuromuscular synapse elimination.

Authors:  Ian W Smith; Michelle Mikesh; Young il Lee; Wesley J Thompson
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

6.  Polyethylene glycol solutions rapidly restore and maintain axonal continuity, neuromuscular structures, and behaviors lost after sciatic nerve transections in female rats.

Authors:  Michelle Mikesh; Cameron L Ghergherehchi; Robert Louis Hastings; Amir Ali; Sina Rahesh; Karthik Jagannath; Dale R Sengelaub; Richard C Trevino; David M Jackson; George D Bittner
Journal:  J Neurosci Res       Date:  2018-04-16       Impact factor: 4.164

7.  Polyethylene glycol treated allografts not tissue matched nor immunosuppressed rapidly repair sciatic nerve gaps, maintain neuromuscular functions, and restore voluntary behaviors in female rats.

Authors:  Michelle Mikesh; Cameron L Ghergherehchi; Sina Rahesh; Karthik Jagannath; Amir Ali; Dale R Sengelaub; Richard C Trevino; David M Jackson; Haley O Tucker; George D Bittner
Journal:  J Neurosci Res       Date:  2018-04-16       Impact factor: 4.164

8.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

9.  Terminal Schwann cells participate in neuromuscular synapse remodeling during reinnervation following nerve injury.

Authors:  Hyuno Kang; Le Tian; Michelle Mikesh; Jeff W Lichtman; Wesley J Thompson
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

10.  A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanism.

Authors:  Yuri Okazaki; Noriyasu Ohshima; Ikumi Yoshizawa; Yasutomi Kamei; Stefania Mariggiò; Keiko Okamoto; Masahiro Maeda; Yoshihito Nogusa; Yuichiro Fujioka; Takashi Izumi; Yoshihiro Ogawa; Yoshitsugu Shiro; Masanobu Wada; Norihisa Kato; Daniela Corda; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.